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The use of bronchoscopes has increased in tuberculosis (TB) diagnostics to circumvent the
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diagnostic challenges that are associated with low sputum volume and smear-negative TB.
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In healthcare facilities situated in low income countries that have a high burden of TB, ade-
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quate decontamination of bronchoscopes is a challenge and often overlooked to save on
time and costs. This amplifies the risk of outbreaks and pseudo-outbreaks due to
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published literature of contaminated bronchoscopes causing pseudo-outbreaks of
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sources, and possible mitigation strategies in low-resource settings.
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Bronchoscopy is an important diagnostic and therapeutic
tool [1,2] in both ambulatory and inpatient healthcare settings
[1]. In the context of pulmonary tuberculosis, bronchoalveolar
lavage or bronchial biopsy have been proven to be essential
diagnostic tools, especially for patients who are unable to
expectorate sufficient sputum samples [3]. However, this
semicritical medical device [4] has also been reported to be
a source of both pseudo-infections and infectious outbreaks
[5]. An indication of an improperly disinfected bronchoscope
acting as a potential reservoir for contamination of both cultures and patients can be gauged by the fact that the bioburden on bronchoscopes postwashing has been estimated to be
around 6.4  104 colony forming units/mL [4]. According to a
metadata analysis conducted from 1974 to 2004 by Seoane-

Vazque et al. [6], the highest number of contaminating incidents was attributed to bronchoscopy and gastrointestinal
endoscopy. In the United States, contaminated fiberoptic
bronchoscopes are estimated to contribute to Mycobacterium
tuberculosis (MTB) nosocomial infections in 460–2300 human
immunodeficiency virus infected patients annually [7].
Additionally, pseudo-outbreaks due to environmental
microorganisms contaminating bronchoscopes have also
been reported [8]. However, data related to bronchoscopeassociated infections and pseudo-outbreaks is underreported
[5], with a dearth of data from low-income and developing
countries.
MTB, nontuberculous mycobacteria (NTM), and Pseudomonas aeruginosa are the most common pathogens
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Table 1 – Reported pseudo-outbreaks of nontuberculous mycobacteria and M. tuberculosis associated with bronchoscopy.
Sample size (No. cases/No. of
bronchoscopies performed)

Reason for suspecting
outbreak

Organism

Retrospective study

14/1270

Retrospective study

7/16
1/16
3/16

Unique strain of M.
cholnea isolated
+ inconsistent culture
findings with clinical
features of patients
Inconsistent culture
findings with clinical
features of patients

Retrospective study

17/21

Retrospective study

15/76

Retrospective casecontrolled study
Surveillance of
bronchoscopes
Prospective-induced
study

18/21
15/19
3/19
—

Unusual No. of rapidly
growing AFB
Not stated
Unusual increase in
isolation
In response to previous
pseudoinfection
Efficacy of different
disinfectants: iodophore,
glutaraldehyde,
peraceticacid
Unusual number of
rapidly growing AFB

Refs.

M. cholonae subsp. abscessus Rinse water

Not performed

[10]

M. cholonae,
M. avium
M. gordonae

Not performed

[11]

RFLP

[12]

Mains water supply
Disinfectant tank
Suction channel

Not performed

[13]

—

[14]

M. cholonae
M. avium intercellularae
M. gordonae

Failure of AER
disinfection procedure
Normal conditions for
disinfection inadequate

—

[15]

—

[16]

M. cholonae

Automated washer &
glutaraldehyde
disinfectant
Incoming water, water
filters, automated
bronchoscope washing
machine
Water filter, hot & cold
water lines

DNA
fingerprinting

[17]

REP-PCR

[18]

Nested PCR
+ RFLP

[19]

PFGE

[20]

Not performed

[21]

RFLP

[22]

Spoligotyping
+ IS6110-based
RFLP

[23]

M. cholonae & M. fortuitum
M. cholonae

Retrospective
+ prospective study

20

Retrospective study

9/57

Isolation at increased
frequency

M. cholonae

Retrospective

22/75

M. avium, M. intercellulare

Prospective study

5/7

Prospective study

4/5

Retrospective cohort
study
Retrospective cohort
study

6/10

Culture isolates were
inconsistent with clinical
features of patients
Isolation of M. gordonae in
BAL
Recurrent cases of
mycobacterial crosscontamination
High incidence of M.
tuberculosis
No cases reported in
hospital the previous
year, suspected
nosocomial outbreak

2/3

M. gordonae
M. tuberculosis

M. tuberculosis
M. tuberculosis

Rinse water
Water tank
Contaminated
glutaraldehyde
disinfectant
Water

Tap water, water supply
channels
Contaminated suction
valve
Hole in bronchoscope
sheath
Inadequate cleaning &
disinfection between
patients use. AER was not
approved

409

Note. AFB = acid-fast bacilli; BAL = bronchoalveolar lavage; M. = Mycobacterium; PCR = polymerase chain reaction; RFLP = restriction fragment length polymorphism.
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Strain similarity

M. xenopi

Identified source of
contamination
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associated with transmission during bronchoscopy and
pseudo-outbreaks [5]. Bronchoscope contamination with
MTB is associated with extensive healthcare costs on the system or on patients (where out-of-pocket expenses are
involved); false-positive cases are often investigated with
repeat cultures and advanced radiological investigations,
receive unnecessary antimycobacterial treatment, and risk
adverse effects of medication. An interesting study by Shim
et al. [9] highlights the limitations of direct amplification tests
created by the presence of false-positive results even by the
presence of a few dead MTB contaminating the bronchoscopes. It is therefore imperative that special attention be
placed on addressing and circumventing not only falsepositive cultures but also false-positive molecular detection
tests such as Xpert MTB/RIF (Cepheid), and molecular probe
assays, due to bronchoscope contamination with
mycobacteria.
Reports of bronchoscope contamination with NTM and
MTB in literature from 1990 to 2016 are briefly outlined in
Table 1. While many NTM-associated outbreaks have been
reported, MTB-associated pseudo-outbreaks have not been
reported with equal frequency.
Possible factors indicated in the failure of the bronchoscope decontamination process and leading to NTM infections include the design of bronchoscopes/endoscopes, an
over-reliance on automated endoscope reprocessors, malfunctioning parts and damage during use, noncompliance of
decontaminating and handling guidelines, and use of contaminated/nonsterile water during washing [24–26]. Reported
causes of bronchoscopy-associated pseudo-outbreaks further
include damage to the internal channel of the bronchoscope,
the ability of bacteria to form biofilms that are difficult to
remove, along with inadequate cleaning with low- or
intermediate-level disinfectants. To prevent bronchoscopeassociated pseudo-outbreaks it is thus imperative to implement standardized decontamination guidelines, such as
those issued by the Centers for Disease Control and Prevention [4], Association for Professionals in Infection Control
and Epidemiology [27], Food and Drug Administration [28],
and European Society of Gastrointestinal EndoscopyEuropean Society of Gastroenterology and Endoscopy Nurses
and Associates [29]. There are, however, differences amongst
these guidelines; for example, for recommendations on
microbiological culture surveillance of bronchoscopes and
on the frequency of culture as well as on interpretation of
data. In light of such differences, a recommendation for an
initial validation study of the protocol to be used demonstrating its effectiveness in particular healthcare settings would be
useful [24]. While automated endoscope reprocessors are recommended by British Society of Gastroenterology and World
Gastroenterology Organisation in advanced settings, manual
cleaning, and disinfection are widely carried out in
resource-limited settings [30]. Ensuring quality control particularly in resource-limited healthcare settings using manual
cleaning and disinfection in particular, is a considerable challenge. Since water is identified as a major environmental
source of bronchoscope contamination, this challenge is
made all the more difficult by limited access to clean water
in many resource-limited settings. The Health Protection
Surveillance Center-Ireland recommends that there should

5 ( 2 0 1 6 ) 4 0 8 –4 1 1

be no viable environmental mycobacteria/100 mL of postflush
water from bronchoscopes [31].
False-positive results of MTB smears, cultures, or molecular tests in bronchoscopically obtained samples are mainly
due to cross-contamination owing to insufficient decontamination of bronchoscopes between use [5,32] or crosscontamination in the laboratory [33,34]. Given that Xpert
MTB/RIF (Cepheid) is a closed system, and risk of crosscontamination in the laboratory is lower, false-positive or
unexpected positive Xpert results on bronchoscope samples
are likely to be a consequence of inadequate decontamination
of the bronchoscope itself. Guidelines, however, do not focus
on decontamination to ensure complete removal of DNA or
antibiotic resistance genes from bronchoscopes.
Awareness and advocacy for stringent monitoring and
surveillance within the bronchoscope suite and disinfection
unit including monitoring of disinfectants used [31] thus
becomes essential. Implementing regular training and competency assessment of personnel concerned with bronchoscope disinfection would ensure compliance with
recommended guidelines.
While implementation and compliance of decontamination guidelines cannot be stressed enough, it is also necessary
that proper communication be established between the clinicians, bronchoscopists, and laboratories so that not only are
pseudo-outbreaks promptly detected but a coordinated
approach is implemented to handle postcontamination
responses.
As access to bronchoscopy, as well as its use in the diagnosis of TB and in particular smear-negative TB increases
[35–37], implementation of policies ensuring proper decontamination of instruments being used as well as safety during
the procedure achieve paramount importance. We therefore
recommend that in addition to development of regional
and/or national guidelines for manual bronchoscope decontamination to remove mycobacteria, innovative and lowcost regional quality assurance programs be introduced to
ensure that specimens obtained through bronchoscopic techniques are free of cross-contaminating mycobacterial DNA.
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